HYAL2 and cancer: Interestingly, virus positive MCCs (VP-MCCs), in contrast to virus negative MCCs (VN-MCCs) show a rather low mutational burden in the host genome and lack typical cancer-driving alterations, indicating that viral oncoprotein expression in VP-MCCs is not only necessary but also largely sufficient for tumorigenesis [11–14].